Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on equity (ROE) is N/A as of the fiscal period ended Sunday, December 31, 2023.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2024 (2023-12-31): -544.42%.
RETURN ON EQUITY (ROE)
N/A
RETURN ON EQUITY (ROE) AVG TTM
-273.26%
RETURN ON EQUITY (ROE) AVG 3Y
-127.46%
RETURN ON EQUITY (ROE) AVG 5Y
-145.24%
RETURN ON EQUITY (ROE) AVG 10Y
-100.78%
RETURN ON EQUITY (ROE) AVG 15Y
-109.04%
RETURN ON EQUITY (ROE) AVG 20Y
-131.07%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Pluri Inc.
Market Cap
$10.59M
Return on Equity (ROE)
N/A
TTM Avg
-273.26%
3Y Avg
-127.46%
5Y Avg
-145.24%
Market Cap
$10.59M
Return on Equity (ROE)
N/A
TTM Avg
-652.54%
3Y Avg
-364.25%
5Y Avg
-252.47%
Market Cap
$10.56M
Return on Equity (ROE)
-177.35%
TTM Avg
-89.62%
3Y Avg
-75.99%
5Y Avg
-59.80%
Market Cap
$10.41M
Return on Equity (ROE)
N/A
TTM Avg
-43.97%
3Y Avg
-160.70%
5Y Avg
-188.29%
Market Cap
$10.51M
Return on Equity (ROE)
-310.94%
TTM Avg
727.99%
3Y Avg
459.17%
5Y Avg
300.20%
Market Cap
$10.37M
Return on Equity (ROE)
N/A
TTM Avg
-22.56%
3Y Avg
-244.57%
5Y Avg
3710.91%
Market Cap
$10.37M
Return on Equity (ROE)
-57.34%
TTM Avg
-65.47%
3Y Avg
-124.96%
5Y Avg
28.05%
Market Cap
$10.82M
Return on Equity (ROE)
-506.63%
TTM Avg
-300.20%
3Y Avg
-300.20%
5Y Avg
-300.20%
Market Cap
$10.26M
Return on Equity (ROE)
-252.37%
TTM Avg
-195.20%
3Y Avg
-116.68%
5Y Avg
-90.09%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pluri Inc. (PLUR) | $10.59M | N/A | -273.26% | -127.46% | -145.24% |
| Senti Biosciences, Inc. (SNTI)vs › | $10.59M | N/A | -652.54% | -364.25% | -252.47% |
| Lisata Therapeutics, Inc. (LSTA)vs › | $10.56M | -177.35% | -89.62% | -75.99% | -59.80% |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.41M | N/A | -43.97% | -160.70% | -188.29% |
| Tvardi Therapeutics, Inc. (TVRD)vs › | $10.51M | -310.94% | 727.99% | 459.17% | 300.20% |
| Polyrizon Ltd. (PLRZ)vs › | $10.37M | N/A | -22.56% | -244.57% | 3710.91% |
| Satellos Bioscience Inc. (MSLE)vs › | $10.37M | -57.34% | -65.47% | -124.96% | 28.05% |
| Caring Brands, Inc. (CABR)vs › | $10.82M | -506.63% | -300.20% | -300.20% | -300.20% |
| Lifeward Ltd. (LFWD)vs › | $10.26M | -252.37% | -195.20% | -116.68% | -90.09% |
| Cerenome, Inc. (CNSY)vs › | $11.02M | -477.54% | -207.60% | 64.51% | -22.91% |
ROE
N/A
ROA
-98.3%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2023-12-31 | -544.42% |
| 2023-09-30 | -305.15% |
| 2023-06-30 | -212.06% |
| 2023-03-31 | -161.91% |
| 2022-12-31 | -142.76% |
| 2022-09-30 | -148.52% |
| 2022-06-30 | -137.29% |
| 2022-03-31 | -122.87% |
| 2021-12-31 | -128.50% |
| 2021-09-30 | -107.98% |
| 2021-06-30 | -87.25% |
| 2021-03-31 | -63.74% |
| 2020-12-31 | -89.16% |
| 2020-09-30 | -62.32% |
| 2020-06-30 | -51.96% |
| 2020-03-31 | -203.09% |
| 2019-12-31 | -197.03% |
| 2019-09-30 | -192.05% |
| 2019-06-30 | -161.80% |
| 2019-03-31 | -423.41% |
| 2018-12-31 | -184.16% |
| 2018-09-30 | -127.86% |
| 2018-06-30 | -91.65% |
| 2018-03-31 | -72.71% |
| 2017-12-31 | -82.50% |
| 2017-09-30 | -118.52% |
| 2017-06-30 | -91.94% |
| 2017-03-31 | -75.80% |
| 2016-12-31 | -104.89% |
| 2016-09-30 | -72.01% |
| 2016-06-30 | -60.92% |
| 2016-03-31 | -51.82% |
| 2015-12-31 | -45.31% |
| 2015-09-30 | -47.07% |
| 2015-06-30 | -42.44% |
| 2015-03-31 | -56.15% |
| 2014-12-31 | -56.23% |
| 2014-09-30 | -52.31% |
| 2014-06-30 | -43.35% |
| 2014-03-31 | -42.04% |
| 2013-12-31 | -39.67% |
| 2013-09-30 | -40.00% |
| 2013-06-30 | -36.81% |
| 2013-03-31 | -28.59% |
| 2012-12-31 | -24.32% |
| 2012-09-30 | -19.80% |
| 2012-06-30 | -39.20% |
| 2012-03-31 | -37.95% |
| 2011-12-31 | -31.78% |
| 2011-09-30 | -33.88% |
| 2011-06-30 | -24.98% |
| 2011-03-31 | -19.38% |
| 2010-12-31 | -142.32% |
| 2010-09-30 | -275.44% |
| 2010-06-30 | -187.21% |
| 2010-03-31 | -276.94% |
| 2009-12-31 | -159.88% |
| 2009-09-30 | -195.73% |
| 2009-06-30 | -195.52% |
| 2009-03-31 | -266.15% |
| 2008-12-31 | -262.92% |
| 2008-09-30 | -334.51% |
| 2008-06-30 | -450.75% |
| 2008-03-31 | -265.63% |
| 2007-12-31 | -230.26% |
| 2007-09-30 | -188.31% |
| 2007-06-30 | -142.93% |
| 2007-03-31 | -218.71% |
| 2006-12-31 | -390.23% |
| 2006-03-31 | -403.01% |
| 2005-12-31 | -238.87% |
| 2005-09-30 | -148.94% |
| 2005-06-30 | -116.36% |
| 2005-03-31 | -194.85% |
| 2004-06-30 | -563.14% |
| 2003-09-30 | -160.21% |
| 2003-06-30 | -92.01% |
